跳至主要内容
临床试验/ACTRN12613000579796
ACTRN12613000579796已完成3 期

Fish oil in anti-inflammatory doses in recent onset rheumatoid arthritis: A randomized, double-blind controlled trial within algorithm-based drug use with DMARD use as the primary outcome.

Royal Adelaide Hospital0 个研究点目标入组 140 人开始时间: 2013年5月23日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • subjects must be 18 years or older, have rheumatoid arthritis (RA) according to the 1987 revised ACR criteria with polyarthritis of less than 12 months’ duration, at least 3 swollen joints and ESR greater than 28 mm/hour and/or CRP greater than 10 mg/dL and be DMARD-naive.

排除标准

  • use of DMARDs other than antimalarials, use of antimalarials for more than 1 month, recent seroconversion to parvovirus, Ross River, Barmah Forest or rubella viruses, antinuclear antibody titre greater than 1:320, hepatitis B, hepatitis C or human immunodeficiency virus, known sensitivity to methotrexate, sulphasalazine or hydroxychloroquine, or systemic disease likely to increase the risk of toxicity to 1 or more of these drugs.

研究者

相似试验